Improved β-cell function after standardized weight reduction in severely obese subjects
- 1 March 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 284 (3) , E557-E565
- https://doi.org/10.1152/ajpendo.00325.2002
Abstract
Islet function was examined in 13 severely obese women [body mass index 46.4 ± 5.5 (SD) kg/m2] before and after standardized 15 and 25% weight reduction (WR) instituted by bariatric surgery. The insulin response to arginine at fasting (AIR1), at 14 mmol/l, and at >25 mmol/l glucose was reduced by 37–50% after 15 and 25% WR ( P ≤ 0.05). Insulin sensitivity was determined as the amount of glucose infused to reach 14 mmol/l divided by the insulin level (M/I), a measure showing a linear correlation with insulin sensitivity during euglycemic hyperinsulinemic clamps ( r = 0.74, P < 0.001) and a hyperbolic relation to AIR1 ( r = −0.63, P < 0.001) in 169 healthy subjects. M/I was increased by 318 ± 182% after 15% ( P = 0.004) and by 489 ± 276% after 25% WR ( P = 0.007). The reduction in insulin secretion was not as large as anticipated from the increased insulin sensitivity, which resulted in an increased disposition index (DI; AIR1 × M/I). Thus DI increased by 95 ± 24% after 15% ( P = 0.018) and by 176 ± 35% after 25% WR ( P = 0.011). This improved β-cell function correlated independently with reduced glucose, triglycerides, and leptin and increased adiponectin levels and was associated with a reduced proinsulin-to-insulin ratio. In contrast, glucagon secretion was not significantly affected by WR. We conclude that WR results in improved β-cell function when related to insulin sensitivity.Keywords
This publication has 48 references indexed in Scilit:
- Disruption of Adiponectin Causes Insulin Resistance and Neointimal FormationJournal of Biological Chemistry, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002
- Minireview: Secondary -Cell Failure in Type 2 Diabetes--A Convergence of Glucotoxicity and LipotoxicityEndocrinology, 2002
- Lack of Suppression of Glucagon Contributes to Postprandial Hyperglycemia in Subjects with Type 2 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999
- Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose ToleranceJournal of Clinical Endocrinology & Metabolism, 1999
- Leptin selectively decreases visceral adiposity and enhances insulin action.Journal of Clinical Investigation, 1997
- Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.Journal of Clinical Investigation, 1996
- Glucose modulation of insulin and glucagon secretion is altered in impaired glucose toleranceJournal of Clinical Endocrinology & Metabolism, 1995
- Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1984